Bioanalytical Systems, Inc. Fourth Quarter Conference Call Rescheduled for Thursday, December 18.Business Editors/Health/Medical Writers WEST LAFAYETTE West Lafayette, city (1990 pop. 25,907), Tippecanoe co., W Ind., a suburb of Lafayette, on the Wabash River; inc. 1924. A primarily residential city, it is the seat of Purdue Univ. , Ind IND Investigational new drug Therapeutics A status assigned by the FDA to a drug before allowing its use in humans, exempting it from premarketing approval requirements so that experimental clinical trials may be conducted. See Phase 1.2, 3 studies, Sponsorship. .--(BUSINESS WIRE)--Nov. 25, 2003 Bioanalytical Systems (Nasdaq:BASI) announced today that the company has rescheduled its conference call to discuss fourth quarter and year-end year-end also year·end n. The end of a year. adj. Occurring or done at the end of the year: a year-end audit. Noun 1. 2003 financial results for the period ended September 30, 2003 to occur on Thursday, December 18. In addition, a press release announcing the results will be released prior to the market opening at 7:30 a.m. EST EST electroshock therapy. EST abbr. electroshock therapy on that day. Peter Kissinger, Chairman and Chief Executive Officer and Michael Silvon, VP - Planning and Development will host the call and be available to answer questions. To participate, please dial the following teleconferencing number five minutes prior to the scheduled conference time.
Date: Thursday, December 18, 2003
Time: 9:00 a.m. Eastern Time
8:00 a.m. Central Time
7:00 a.m. Mountain Time
6:00 a.m. Pacific Time
Dial-In Number: 800-275-3939 (Domestic)
1-973-409-9259 (International)
Also, a live Webcast of the conference call will be available at www.bioanalytical.com. For those unable to participate there will be a replay available from Thursday December 18 at 11:00 a.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT , through 11:50 p.m. EDT on Thursday December 22, 2003. To listen to the replay, please dial:
Domestic: 877-519-4471
International: 1-973-341-3080
Replay Pin Code: 4343087
A replay of the Webcast will also be available at www.bioanalytical.com. BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development and medical device companies. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit http://www.bioanalytical.com for more about BASi. This release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the development of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks Operating risk The inherent or fundamental risk of a firm, without regard to financial risk. The risk that is created by operating leverage. Also called business risk. detailed in the company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion